S-3 424B5 EX-FILING FEES 333-281359 0001816736 Disc Medicine, Inc. N/A Y N 0001816736 2026-11-05 2026-11-05 0001816736 1 2026-11-05 2026-11-05 0001816736 1 2026-11-05 2026-11-05 0001816736 2 2026-11-05 2026-11-05 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

Disc Medicine, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, par value $0.0001 per share 457(o) $ 189,925,765.00 0.000087 $ 16,523.54
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 189,925,765.00

$ 16,523.54

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 16,523.54

Net Fee Due:

$ 0.00

Offering Note

1

The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the "Securities Act"), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant initially deferred payment of all of the registration fee for its Registration Statement on Form S-3ASR (Registration No. 333-281359), which was filed with the Securities and Exchange Commission on August 8, 2024. Pursuant to Rule 457(p) under the Securities Act, the registrant hereby applies $16,523.54 of the registration fee previously paid in connection with the Prior Prospectus Supplement (as defined below) to offset the registration fees that are payable in connection with the registration of securities on this prospectus supplement.

Table 2: Fee Offset Claims and Sources ☐Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims 1 Disc Medicine, Inc. S-3 333-281359 08/08/2024 $ 16,523.54 Equity Common Stock, par value $0.0001 per share $ 189,925,765.25
Fee Offset Sources Disc Medicine, Inc. S-3 333-275652 11/20/2023 $ 59,040.00

Rule 457(p) Statement of Withdrawal, Termination, or Completion:

1

On August 8, 2024, the registrant filed a registration statement on Form S-3ASR (File No. 333-281359) and on November 15, 2024, the registrant filed a sales agreement prospectus supplement covering the offering, issuance and sale by the registrant of up to an aggregate of $200,000,000 of its common stock pursuant to its "at-the-market" offering program with Cantor Fitzgerald & Co. (the "Prior Prospectus Supplement"). The registrant incurred a filing fee in the amount of $30,620 in connection with the Prior Prospectus Supplement, which fee was calculated pursuant to Rule 457(o) under the Securities Act. Of this amount, $25,144.84 was offset pursuant to Rule 457(p) under the Securities Act by previously paid registration fees attributable to unsold securities under the registrant's prior "at-the-market" offering with Jefferies LLC, registered pursuant to the registrant's registration statement on Form S-3 filed on November 20, 2023 (File No. 333-275652) (the "Source Registration Statement"). The registrant previously paid an aggregate registration fee of $59,040 in connection with the Source Registration Statement (based on the filing fee rate in effect at the time of the filing of the Source Registration Statement). As of the date of filing of this prospectus supplement, $189,925,765.25 of shares of the registrant's common stock (the "Unsold Securities") remained unsold under the Prior Prospectus Supplement, representing $29,077.63 in registration fees attributable to such Unsold Securities under the Prior Prospectus Supplement. Pursuant to Rule 457(p) under the Securities Act, filing fees in the amount of $16,523.54 relating to a portion of the Unsold Securities are being carried forward, and the offering pursuant to the Prior Prospectus Supplement is deemed terminated.

Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date

Narrative Disclosure
The maximum aggregate offering price of the securities to which the prospectus relates is $189,925,765.00. The prospectus is a final prospectus for the related offering.